ARG43021

anti-Glycogen Synthase 2 antibody

anti-Glycogen Synthase 2 antibody for Western blot and Mouse

Overview

Product Description Rabbit Polyclonal antibody recognizes Glycogen Synthase 2
Tested Reactivity Ms
Tested Application WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name Glycogen Synthase 2
Antigen Species Human
Immunogen Recombinant fusion protein corresponding to aa. 594-703 of Glycogen Synthase 2 (NP_068776.2).
Conjugation Un-conjugated
Alternate Names Glycogen [starch] synthase, liver; EC 2.4.1.11

Application Instructions

Application Suggestion
Tested Application Dilution
WB1:500 - 1:3000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control Mouse liver
Observed Size ~85 - 90 kDa

Properties

Form Liquid
Purification Affinity purified.
Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 232493 Mouse GYS2

Swiss-port # Q8VCB3 Mouse Glycogen [starch] synthase, liver

Gene Symbol GYS2
Gene Full Name glycogen synthase 2 (liver)
Background The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
Function Transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan. [UniProt]
Calculated MW 81 kDa
PTM Primed phosphorylation at Ser-657 (site 5) by CSNK2A1 and CSNK2A2 is required for inhibitory phosphorylation at Ser-641 (site 3a), Ser-645 (site 3b), Ser-649 (site 3c) and Ser-653 (site 4) by GSK3A an GSK3B. Dephosphorylation at Ser-641 and Ser-645 by PP1 activates the enzyme (By similarity). Phosphorylation at Ser-8 is not required for interaction with GYG1 (By similarity). Interaction with GYG1 does not regulate the phosphorylation at Ser-8 and Ser-641 (By similarity). [UniProt]